Inox India Ltd

Q2 FY24 Earnings Call Analysis

Industrial Products

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 3orderbook: No
💰

fundraise

Any current/future new fundraising through debt or equity?

- As of June 2024, the company has almost nil total debt and a comfortable net cash position of around Rs. 180 crores. - This strong cash position provides adequate room to raise debt in the future if needed. - There is no explicit mention of any ongoing or planned fundraising through debt or equity in the current quarter. - The company has ample capacity and is focusing on growth using internal accruals and existing resources. - If growth opportunities require, they are open to further CAPEX investments, supported by potential future debt mobilization.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- The company has ample land available at Savli for future expansions and is prepared to invest in new factories or sheds as growth demands. - Currently, construction for the cryo shop at Savli is underway following the completion of the keg shop. - A planned capital expenditure (CAPEX) of around Rs. 80 crores is allocated for new machinery and building at Savli. - The combined capacity of Kalol and Kandla facilities is around Rs. 1,200-1,300 crores, with Savli expected to add Rs. 300-500 crores capacity in the next 1-2 years. - Additional CAPEX will be considered as needed based on growth potential. - The company maintains a comfortable net cash position (~Rs. 180 crores as of June 2024) and nearly zero debt, providing room for further investments.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- The company targets an 18%-20% growth rate in sales/revenue in the medium term and next few years. - The growth will be driven by multiple sectors: Industrial Gases (IG), LNG, Cryo Scientific, and Sustainable Packaging (beer kegs). - New products and applications, especially in hydrogen, helium containers, and LNG fueling stations, are expected to contribute substantially. - While some sectors move faster than others, overall growth is steady and aligned with market opportunities. - Over the next 3-4 years, the company aims to cross revenue of around Rs. 2,000 crores. - Growth beyond 20%-25% is considered ambitious; current guidance is conservative given industry implementation speeds. - Order backlog (~Rs. 1,100 crores) plus additional short-term orders provide confidence in achieving growth targets. - Expansion of capacity (Savli unit and others) supports scaling sales up to Rs. 1,800+ crores based on existing facilities.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- The company targets a growth rate of 18%-20% in revenue over the next few years, reflecting sustainable and steady expansion across its sectors (Industrial Gases, LNG, Cryo Scientific, and Sustainable Packaging). - Earnings and operating profits are expected to grow correspondingly as new products and applications (e.g., hydrogen, LNG fuel tanks, beer KEGs, and MRI-related products) start contributing more significantly. - Order backlog remains strong at around Rs. 1,100 crores, with confidence to surpass revenue targets through both long-gestation and short-gestation standard/non-standard products. - EPS growth aligns with revenue growth targets, considering steady EBITDA margins (~25%) and controlled expenses. - Potential exists for faster growth if green energy sectors (hydrogen economy, LNG adoption) accelerate quicker than forecasted. - CAPEX investments ongoing (e.g., Rs. 80 crores in Savli unit expansion) to support scaling capacity and future earnings growth. - Near-term margins may experience some pressure due to rising employee/labor costs and logistical challenges, but these are expected to be managed effectively.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- As of June 30, 2024, the order backlog stands at Rs. 1,105 crores. - Distribution of orders: 50% Industrial Gases (IG), 23% LNG, and 27% Cryo Scientific. - Exports constitute about 51% of the total order backlog. - The backlog has been relatively stable over the past four quarters, ranging between Rs. 1,050 to Rs. 1,100 crores. - Standard products in the backlog typically have delivery timelines of 2-3 months, enabling monthly billing of Rs. 50-60 crores from such orders. - The company expects to add an additional Rs. 400-500 crores from standard products during the fiscal year. - Confidence expressed in securing an extra Rs. 300 crores of orders, including contributions from short-cycle products like KEGs. - Order inflow for Q1 FY25 was Rs. 310 crores, with 46% from IG, 26% from LNG, and 28% from Cryo Scientific.